Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report
2024

Germline TRAF2 Variant in Young Adult with Medulloblastoma

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Vo Josh N., Franson Andrea, Waszak Sebastian M., Wu Yi-Mi, Becker Nicole, Chinnaiyan Arul M., Robinson Dan R.

Primary Institution: University of Michigan, Ann Arbor, MI USA

Hypothesis

Is a germline loss-of-function variant in TRAF2 associated with medulloblastoma in young adults?

Conclusion

The study identifies a rare germline variant in TRAF2 that may contribute to the development of medulloblastoma in a young adult patient.

Supporting Evidence

  • A rare heterozygous germline loss-of-function variant in TRAF2 was identified in the patient.
  • The tumor exhibited a unique molecular profile compared to other medulloblastomas.
  • Integrative genomics revealed biallelic loss of TRAF2 in the medulloblastoma genome.

Takeaway

A young woman with brain cancer had a rare gene change that might have caused her illness, showing that some cancers can be linked to inherited genes.

Methodology

Next-generation sequencing was performed on tumor and matched normal tissue to identify genetic variants.

Limitations

Further familial genetic testing was not possible to ascertain parental inheritance of the variant.

Participant Demographics

The patient was a 21-year-old woman with no significant past medical history.

Digital Object Identifier (DOI)

10.1186/s40478-024-01896-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication